Stoke Therapeutics Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the third quarter 2026 to a ratio of 4.32, this is below the company average, and notable indication of worsening business environment. Average receivable collection period, for the Stoke Therapeutics Inc in Sep 30 2026 quarter, has decreased to 84 days, compared to 89 days, in the Jun 30 2026 quarter.

If we take a look into Healthcare sector 430 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 2009, from overall ranking in the second quarter 2026 at 2653.

What is Receivable Turnover Ratio?
What is Stoke Therapeutics Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

STOK Receivables Turnover Ratio	(Sep 30 2026) III. Quarter	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter
Y / Y Receivable Change	-7.62 %	-	-	-	-
Y / Y Revenue Change	5.86 %	-32.51 %	-96.07 %	-93.8 %	117.25 %
Receivable Turnover Ratio (TTM)	4.32	4.12	6.54	48.58	88.94
STOK's Total Ranking	# 2009	# 2653	# 1873	# 1702	#
Accounts Receivable average collection period days	84	89	56	8	4
Seq. Receivable Change	19 %	61.29 %	-25.02 %	-35.81 %	-
Seq. Revenue Change	20.7 %	49.7 %	344.29 %	-86.81 %	-23.05 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 131
Healthcare Sector	# 431
Overall Market	# 2009

Receivable Turnover Ratio Statistics
High	Average	Low
88.94	37.04	4.12
(Sep 30 2025)		(Jun 30 2026)

STOK Company Profile • Back to STOK Efficiency Comparisons • Compare STOK Receivables Turnover Ratio to its Competitors

Financial Statements
Stoke Therapeutics Inc 's Accounts Receivable	$ 9 Millions	Visit STOK's Balance sheet
Stoke Therapeutics Inc 's Sales TTM	$ 28 Millions	Visit STOK's Income Statement
Sources of STOK's Revenues		Visit STOK's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
STOK's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
STOK's Growth Rates	STOK's Roa	STOK's Inventory Turnover Ratio	STOK's Dividend Comparisons
STOK's Profitability Ratios	STOK's Roi	STOK's Asset Turnover Ratio	STOK's Dividend Growth
STOK's Valuation Ratios	STOK's Roe	STOK's Financial Strength Ratios	STOK's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Sep 30 2026	Receivable at quarter ending Sep 30 2026
Pacs Group Inc	8.88	$ 5,705.049 Millions	$ 642.729 Millions
Lexicon Pharmaceuticals Inc	8.77	$ 38.537 Millions	$ 4.396 Millions
Axogen inc	8.71	$ 266.926 Millions	$ 30.654 Millions
Avita Medical Inc	8.65	$ 84.683 Millions	$ 9.795 Millions
Ensign Group Inc	8.62	$ 5,674.305 Millions	$ 658.477 Millions
Pediatrix Medical Group Inc	8.57	$ 1,959.124 Millions	$ 228.471 Millions
Tenet Healthcare Corp	8.54	$ 22,154.000 Millions	$ 2,593.250 Millions
Brightspring Health Services Inc	8.50	$ 9,479.144 Millions	$ 1,114.763 Millions
Sotera Health Company	8.49	$ 1,230.250 Millions	$ 144.974 Millions
Acadia Pharmaceuticals Inc	8.46	$ 1,202.301 Millions	$ 142.117 Millions
Novavax inc	8.33	$ 411.649 Millions	$ 49.414 Millions
Tactile Systems Technology Inc	8.23	$ 357.176 Millions	$ 43.385 Millions
Penumbra Inc	8.22	$ 1,560.334 Millions	$ 189.735 Millions
Inspire Medical Systems inc	8.15	$ 882.194 Millions	$ 108.207 Millions
Adapthealth Corp	8.14	$ 3,152.043 Millions	$ 387.280 Millions
Rhythm Pharmaceuticals Inc	8.03	$ 280.748 Millions	$ 34.950 Millions
Alphatec Holdings Inc	7.91	$ 839.652 Millions	$ 106.153 Millions
Exelixis Inc	7.89	$ 2,496.861 Millions	$ 316.636 Millions
Henry Schein Inc	7.84	$ 13,734.000 Millions	$ 1,752.000 Millions
Idexx Laboratories Inc	7.78	$ 4,663.675 Millions	$ 599.701 Millions
Madrigal Pharmaceuticals Inc	7.70	$ 1,427.940 Millions	$ 185.380 Millions
Lemaitre Vascular Inc	7.66	$ 269.938 Millions	$ 35.235 Millions
Pulmonx Corporation	7.56	$ 89.176 Millions	$ 11.791 Millions
Merit Medical Systems Inc	7.53	$ 1,612.236 Millions	$ 214.065 Millions
Cerus Corporation	7.48	$ 226.798 Millions	$ 30.308 Millions
Insmed Inc	7.45	$ 1,479.040 Millions	$ 198.502 Millions
Novocure Limited	7.44	$ 725.388 Millions	$ 97.525 Millions
Edap Tms Sa	7.44	$ 111.370 Millions	$ 14.974 Millions
Intuitive Surgical Inc	7.44	$ 12,115.600 Millions	$ 1,629.350 Millions
Quest Diagnostics Inc	7.43	$ 11,841.000 Millions	$ 1,593.250 Millions

Date modified: 2026-11-04T15:26:34+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.